ミュータントのp53は,メバロナート経路経由で乳腺組織構造を破壊する
William A Freed-Pastor1, Hideaki Mizuno, Xi Zhao
1Department of Biological Sciences, Columbia University, New York, NY 10027, USA.
Cell
|January 24, 2012
まとめ
ミュータントのp53は,メバロナート経路を向上させ,細胞構造を変えることで,乳がんを誘発する. スタチンでこの経路をターゲットにすることは,p53-変異した腫瘍に対する潜在的な治療戦略を提供します.
科学分野:
- 腫瘍学 腫瘍学
- 分子生物学は分子生物学である.
- 細胞生物学 細胞生物学
背景:
- 腫瘍抑制遺伝子のp53の変異は,ヒトのがんに共通しています.
- 変異したp53タンパク質は,腫瘍の発達と進行を促すことができます.
- 乳がん細胞は,正常な細胞と比較して,3D培養で無秩序な形状を示します.
研究 の 目的:
- 乳がん細胞形態学における変異性p53の役割を調査し,基礎となる分子機構を特定する.
- p53変異の乳がんにおける潜在的治療標的としてメバロナート経路を探求する.
主な方法:
- 乳腺上皮細胞の3次元 (3D) 細胞培養モデルを使用しました.
- ゲノム全体の発現分析を行い,変異性p53.3によって影響を受ける経路を特定しました.
- スタチンとステロールバイオシンセシスの中間物質が細胞現象型に与える影響を調査した.
- 転写因子解析を用いて,変異p53とステロール遺伝子プロモーターの関連性を分析した.
- ヒト乳腺腫瘍データセットと相関する遺伝子発現データ.
主要な成果:
- 変異したp53の枯渇は,乳がん細胞の正常なアチナーのような形態を回復させた.
- メバロナート経路は,変異性p53.3によって著しく上調されていると特定されました.
- メバロナート経路は,組織構造に対する変異p53のフェノタイプ効果のために必要かつ十分であった.
- 変異したp53は,部分的にSREBP転写因子を介して,ステロール遺伝子プロモーターと相互作用します.
- ステロール生物合成遺伝子の高い発現は,ヒトの乳がんにおけるp53変異と相関する.
結論:
- ミュータントのp53は,メバロナート経路のアップレギュレーションを通じて,異常な乳腺組織構造を駆動する.
- メバロナート経路は,変異性p53の腫瘍学的機能の重要な媒介者である.
- メバロナート経路をターゲットに,スタチンを用いた可能性があり,p53-変異性乳がんに対する有望な治療戦略です.
関連する概念動画
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
Epigenetic Regulation
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
DNA Damage can Stall the Cell Cycle
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...


